ABIOMED INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$726.9M

2,047 transactions

Summary

ABIOMED INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $14.5MSales: $434.8M37 insiders

Date	Insider	Type	Value
2022-12-22	Van Gorder Chris	A	$0
2022-12-22	Rolle Myron L	D	$0
2022-12-22	THOMAS PAUL	D	—
2022-12-22	Johnson Paula A	D	$0
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	D	—
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	D	—
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	D	—
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	A	—
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	D	—
2022-12-22	Began Marc A(VP & GENERAL COUNSEL)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	A	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	—
2022-12-22	Greenfield Andrew J(VP, CHIEF COMMERCIAL OFFICER)	D	$0
2022-12-22	MINOGUE MICHAEL R(CHAIRMAN, PRESIDENT, CEO)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ABIOMED INC — Contributions, Lobbying & Contracts | Poliscope